About FNDR
FNDR is a company based in Bengaluru (India) founded in 2013 by R K Shandil. The company has 29 employees as of April 05, 2024. FNDR offers products and services including Drug Discovery Pipeline, Contract Preclinical Studies, and Diagnostics and Devices Program. FNDR operates in a competitive market with competitors including Biological E, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and Freeline, among others.
- Headquarter Bengaluru, India
- Employees 29 as on 05 Apr, 2024
- Founders R K Shandil
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Foundation For Neglected Disease Research
- Date of Incorporation 01 Sep, 2014
- Jurisdiction Bengaluru, Karnataka, India
-
Annual Revenue
$1.37 M (USD)46as on Mar 31, 2023
-
Net Profit
$282.7 K (USD)111as on Mar 31, 2023
-
EBITDA
$295.12 K (USD)1.17as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
29
as on Apr 05, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of FNDR
FNDR offers a comprehensive portfolio of products and services, including Drug Discovery Pipeline, Contract Preclinical Studies, and Diagnostics and Devices Program.
Develops therapeutics for tuberculosis and malaria diseases
Conducts in vitro and animal tests for pathogens
Focuses on tools for infectious disease detection
Funding Insights of FNDR
Detailed funding history for FNDR
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by FNDR
Investment portfolio details for FNDR
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - FNDR
Detailed financials for FNDR
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fndr Comparisons
Peer comparison for FNDR
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of FNDR
FNDR operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological E, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and Freeline, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of infectious diseases
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| Locked | Locked | Locked |
Novel anti-infectives for bacterial and fungal infections are developed.
|
|
| Locked | Locked | Locked |
Gene therapy platform is developed for chronic disease treatments.
|
|
| Locked | Locked | Locked |
Prophylactic vaccines for infectious diseases are developed and advanced.
|
Detailed competitors of FNDR
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fndr
Complete news archive for FNDR
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FNDR
FNDR was founded in 2013.
FNDR is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
As of Apr 05, 2024, the latest employee count at FNDR is 29.
Annual revenue of FNDR is $1.37M as on Mar 31, 2023.
Developer of therapeutics and diagnostics for neglected infectious diseases. This organization conducts research and development in infectious disease drug discovery and development, focusing on therapeutics and diagnostics. It offers preclinical in vitro and animal studies for various pathogens under a fee-for-service model. The company also engages in collaborations with other institutions to advance its research at both preclinical and clinical stages. Funding is primarily through grants and donations. The organization also has a community outreach program focused on disease awareness and skill-building.
FNDR's top competitors include Vaxcyte, Serum Institute of India and Biological E.
FNDR offers Drug Discovery Pipeline, Contract Preclinical Studies, and Diagnostics and Devices Program.